Pfizer (NYSE:PFE) Receives “Buy” Rating from Guggenheim
Pfizer (NYSE:PFE – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Guggenheim in a research report issued to clients and investors on Tuesday,Benzinga reports. A number of other equities analysts have also recently weighed in on the stock. StockNews.com cut shares of Pfizer from a “strong-buy” rating to a “buy” […]
Pfizer (NYSE:PFE – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Guggenheim in a research report issued to clients and investors on Tuesday,Benzinga reports. A number of other equities analysts have also recently weighed in on the stock. StockNews.com cut shares of Pfizer from a “strong-buy” rating to a “buy” […]
